nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—Sustained ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.046	0.123	CcSEcCtD
Dipyridamole—PDE5A—pulmonary artery—dilated cardiomyopathy	0.0298	0.093	CbGeAlD
Dipyridamole—PDE1C—cardiac ventricle—dilated cardiomyopathy	0.0204	0.0638	CbGeAlD
Dipyridamole—PDE1C—myocardium—dilated cardiomyopathy	0.0192	0.06	CbGeAlD
Dipyridamole—PRUNE—myocardium—dilated cardiomyopathy	0.0173	0.0541	CbGeAlD
Dipyridamole—ABCB1—Lisinopril—dilated cardiomyopathy	0.0167	0.532	CbGbCtD
Dipyridamole—ABCB1—Spironolactone—dilated cardiomyopathy	0.0147	0.468	CbGbCtD
Dipyridamole—PDE1C—heart—dilated cardiomyopathy	0.0134	0.0419	CbGeAlD
Dipyridamole—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.0127	0.0339	CcSEcCtD
Dipyridamole—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.0123	0.0329	CcSEcCtD
Dipyridamole—PRUNE—heart—dilated cardiomyopathy	0.0121	0.0378	CbGeAlD
Dipyridamole—PDE6D—heart—dilated cardiomyopathy	0.0117	0.0365	CbGeAlD
Dipyridamole—PDE6B—heart—dilated cardiomyopathy	0.0115	0.0359	CbGeAlD
Dipyridamole—Gastric irritation—Furosemide—dilated cardiomyopathy	0.0114	0.0304	CcSEcCtD
Dipyridamole—PDE11A—heart—dilated cardiomyopathy	0.0107	0.0334	CbGeAlD
Dipyridamole—PDE2A—cardiac ventricle—dilated cardiomyopathy	0.0106	0.033	CbGeAlD
Dipyridamole—PRUNE—cardiac atrium—dilated cardiomyopathy	0.0103	0.0323	CbGeAlD
Dipyridamole—Breast pain—Spironolactone—dilated cardiomyopathy	0.00931	0.0249	CcSEcCtD
Dipyridamole—PDE8A—cardiac ventricle—dilated cardiomyopathy	0.00908	0.0284	CbGeAlD
Dipyridamole—PDE8A—myocardium—dilated cardiomyopathy	0.00854	0.0267	CbGeAlD
Dipyridamole—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.0084	0.0225	CcSEcCtD
Dipyridamole—PDE7B—heart—dilated cardiomyopathy	0.00832	0.026	CbGeAlD
Dipyridamole—PDE10A—heart—dilated cardiomyopathy	0.00695	0.0217	CbGeAlD
Dipyridamole—PDE2A—heart—dilated cardiomyopathy	0.00695	0.0217	CbGeAlD
Dipyridamole—PDE1B—heart—dilated cardiomyopathy	0.00688	0.0215	CbGeAlD
Dipyridamole—PDE8B—heart—dilated cardiomyopathy	0.00663	0.0207	CbGeAlD
Dipyridamole—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00657	0.0176	CcSEcCtD
Dipyridamole—PDE3B—heart—dilated cardiomyopathy	0.00647	0.0202	CbGeAlD
Dipyridamole—Renal pain—Lisinopril—dilated cardiomyopathy	0.0063	0.0168	CcSEcCtD
Dipyridamole—PDE3A—cardiac ventricle—dilated cardiomyopathy	0.00602	0.0188	CbGeAlD
Dipyridamole—PDE8A—heart—dilated cardiomyopathy	0.00596	0.0186	CbGeAlD
Dipyridamole—PDE2A—cardiac atrium—dilated cardiomyopathy	0.00594	0.0186	CbGeAlD
Dipyridamole—PDE1A—heart—dilated cardiomyopathy	0.00577	0.018	CbGeAlD
Dipyridamole—PDE3A—myocardium—dilated cardiomyopathy	0.00566	0.0177	CbGeAlD
Dipyridamole—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.00566	0.0177	CbGeAlD
Dipyridamole—Injection site pain—Furosemide—dilated cardiomyopathy	0.00541	0.0145	CcSEcCtD
Dipyridamole—ABCC5—myocardium—dilated cardiomyopathy	0.00533	0.0166	CbGeAlD
Dipyridamole—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00531	0.0142	CcSEcCtD
Dipyridamole—SLC29A1—cardiac ventricle—dilated cardiomyopathy	0.0052	0.0162	CbGeAlD
Dipyridamole—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00516	0.0138	CcSEcCtD
Dipyridamole—PDE8A—cardiac atrium—dilated cardiomyopathy	0.0051	0.0159	CbGeAlD
Dipyridamole—ADA—heart—dilated cardiomyopathy	0.00491	0.0153	CbGeAlD
Dipyridamole—SLC29A1—myocardium—dilated cardiomyopathy	0.00489	0.0153	CbGeAlD
Dipyridamole—PDE4A—heart—dilated cardiomyopathy	0.00478	0.0149	CbGeAlD
Dipyridamole—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00433	0.0116	CcSEcCtD
Dipyridamole—PDE5A—heart—dilated cardiomyopathy	0.00406	0.0127	CbGeAlD
Dipyridamole—PDE3A—heart—dilated cardiomyopathy	0.00395	0.0124	CbGeAlD
Dipyridamole—Breast pain—Lisinopril—dilated cardiomyopathy	0.0038	0.0102	CcSEcCtD
Dipyridamole—ABCC5—heart—dilated cardiomyopathy	0.00372	0.0116	CbGeAlD
Dipyridamole—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00367	0.00981	CcSEcCtD
Dipyridamole—Alopecia—Spironolactone—dilated cardiomyopathy	0.0036	0.00963	CcSEcCtD
Dipyridamole—SLC29A1—heart—dilated cardiomyopathy	0.00341	0.0107	CbGeAlD
Dipyridamole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00341	0.00912	CcSEcCtD
Dipyridamole—PDE3A—cardiac atrium—dilated cardiomyopathy	0.00338	0.0106	CbGeAlD
Dipyridamole—Thirst—Furosemide—dilated cardiomyopathy	0.00337	0.009	CcSEcCtD
Dipyridamole—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00335	0.00897	CcSEcCtD
Dipyridamole—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00331	0.00886	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00331	0.00885	CcSEcCtD
Dipyridamole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00329	0.0088	CcSEcCtD
Dipyridamole—Malaise—Spironolactone—dilated cardiomyopathy	0.0032	0.00855	CcSEcCtD
Dipyridamole—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00318	0.00993	CbGeAlD
Dipyridamole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00299	0.00798	CcSEcCtD
Dipyridamole—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00295	0.00788	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00293	0.00783	CcSEcCtD
Dipyridamole—SLC29A1—cardiac atrium—dilated cardiomyopathy	0.00292	0.00912	CbGeAlD
Dipyridamole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00291	0.00776	CcSEcCtD
Dipyridamole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0029	0.00774	CcSEcCtD
Dipyridamole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00289	0.00772	CcSEcCtD
Dipyridamole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00284	0.00758	CcSEcCtD
Dipyridamole—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00275	0.00736	CcSEcCtD
Dipyridamole—ABCC4—heart—dilated cardiomyopathy	0.00258	0.00805	CbGeAlD
Dipyridamole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00258	0.00688	CcSEcCtD
Dipyridamole—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00254	0.00678	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0025	0.00668	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00249	0.00664	CcSEcCtD
Dipyridamole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00248	0.00662	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00246	0.00656	CcSEcCtD
Dipyridamole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00239	0.00638	CcSEcCtD
Dipyridamole—Urticaria—Spironolactone—dilated cardiomyopathy	0.0023	0.00615	CcSEcCtD
Dipyridamole—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00229	0.00611	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0022	0.00587	CcSEcCtD
Dipyridamole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00217	0.00579	CcSEcCtD
Dipyridamole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00213	0.0057	CcSEcCtD
Dipyridamole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00207	0.00553	CcSEcCtD
Dipyridamole—Pruritus—Spironolactone—dilated cardiomyopathy	0.00205	0.00548	CcSEcCtD
Dipyridamole—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00205	0.00547	CcSEcCtD
Dipyridamole—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00203	0.00541	CcSEcCtD
Dipyridamole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00203	0.00541	CcSEcCtD
Dipyridamole—Angiopathy—Furosemide—dilated cardiomyopathy	0.00201	0.00538	CcSEcCtD
Dipyridamole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.002	0.00535	CcSEcCtD
Dipyridamole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00198	0.0053	CcSEcCtD
Dipyridamole—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00198	0.0053	CcSEcCtD
Dipyridamole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00192	0.00512	CcSEcCtD
Dipyridamole—Flatulence—Furosemide—dilated cardiomyopathy	0.0019	0.00509	CcSEcCtD
Dipyridamole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00189	0.00505	CcSEcCtD
Dipyridamole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00186	0.00496	CcSEcCtD
Dipyridamole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00184	0.00492	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00183	0.00488	CcSEcCtD
Dipyridamole—Rash—Spironolactone—dilated cardiomyopathy	0.00183	0.00488	CcSEcCtD
Dipyridamole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00182	0.00488	CcSEcCtD
Dipyridamole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00182	0.00486	CcSEcCtD
Dipyridamole—Headache—Spironolactone—dilated cardiomyopathy	0.00181	0.00485	CcSEcCtD
Dipyridamole—Anaemia—Furosemide—dilated cardiomyopathy	0.00178	0.00477	CcSEcCtD
Dipyridamole—Vertigo—Furosemide—dilated cardiomyopathy	0.00173	0.00464	CcSEcCtD
Dipyridamole—Nausea—Spironolactone—dilated cardiomyopathy	0.00172	0.0046	CcSEcCtD
Dipyridamole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00169	0.00453	CcSEcCtD
Dipyridamole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00167	0.00446	CcSEcCtD
Dipyridamole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00166	0.00445	CcSEcCtD
Dipyridamole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00165	0.00441	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00163	0.00436	CcSEcCtD
Dipyridamole—Dry mouth—Furosemide—dilated cardiomyopathy	0.00161	0.0043	CcSEcCtD
Dipyridamole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00158	0.00421	CcSEcCtD
Dipyridamole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00155	0.00415	CcSEcCtD
Dipyridamole—Shock—Furosemide—dilated cardiomyopathy	0.00155	0.00414	CcSEcCtD
Dipyridamole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00155	0.00413	CcSEcCtD
Dipyridamole—Flushing—Lisinopril—dilated cardiomyopathy	0.00154	0.00413	CcSEcCtD
Dipyridamole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00154	0.00412	CcSEcCtD
Dipyridamole—Skin disorder—Furosemide—dilated cardiomyopathy	0.00153	0.00409	CcSEcCtD
Dipyridamole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00152	0.00407	CcSEcCtD
Dipyridamole—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00151	0.00404	CcSEcCtD
Dipyridamole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.0015	0.00401	CcSEcCtD
Dipyridamole—Chills—Lisinopril—dilated cardiomyopathy	0.00149	0.00399	CcSEcCtD
Dipyridamole—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00149	0.00397	CcSEcCtD
Dipyridamole—Hypotension—Furosemide—dilated cardiomyopathy	0.00147	0.00394	CcSEcCtD
Dipyridamole—Alopecia—Lisinopril—dilated cardiomyopathy	0.00147	0.00393	CcSEcCtD
Dipyridamole—Flatulence—Lisinopril—dilated cardiomyopathy	0.00143	0.00382	CcSEcCtD
Dipyridamole—Tension—Lisinopril—dilated cardiomyopathy	0.00142	0.0038	CcSEcCtD
Dipyridamole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00142	0.00379	CcSEcCtD
Dipyridamole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00142	0.00378	CcSEcCtD
Dipyridamole—Nervousness—Lisinopril—dilated cardiomyopathy	0.00141	0.00376	CcSEcCtD
Dipyridamole—Back pain—Lisinopril—dilated cardiomyopathy	0.0014	0.00375	CcSEcCtD
Dipyridamole—Somnolence—Furosemide—dilated cardiomyopathy	0.0014	0.00374	CcSEcCtD
Dipyridamole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00139	0.00372	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00136	0.00364	CcSEcCtD
Dipyridamole—Fatigue—Furosemide—dilated cardiomyopathy	0.00136	0.00363	CcSEcCtD
Dipyridamole—Tremor—Lisinopril—dilated cardiomyopathy	0.00136	0.00363	CcSEcCtD
Dipyridamole—Pain—Furosemide—dilated cardiomyopathy	0.00135	0.0036	CcSEcCtD
Dipyridamole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00134	0.00359	CcSEcCtD
Dipyridamole—Anaemia—Lisinopril—dilated cardiomyopathy	0.00134	0.00358	CcSEcCtD
Dipyridamole—Angioedema—Lisinopril—dilated cardiomyopathy	0.00132	0.00354	CcSEcCtD
Dipyridamole—Malaise—Lisinopril—dilated cardiomyopathy	0.00131	0.00349	CcSEcCtD
Dipyridamole—Vertigo—Lisinopril—dilated cardiomyopathy	0.0013	0.00348	CcSEcCtD
Dipyridamole—Syncope—Lisinopril—dilated cardiomyopathy	0.0013	0.00347	CcSEcCtD
Dipyridamole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0013	0.00347	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00129	0.00344	CcSEcCtD
Dipyridamole—Palpitations—Lisinopril—dilated cardiomyopathy	0.00128	0.00342	CcSEcCtD
Dipyridamole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00127	0.0034	CcSEcCtD
Dipyridamole—Cough—Lisinopril—dilated cardiomyopathy	0.00126	0.00338	CcSEcCtD
Dipyridamole—Urticaria—Furosemide—dilated cardiomyopathy	0.00125	0.00335	CcSEcCtD
Dipyridamole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00125	0.00333	CcSEcCtD
Dipyridamole—Chest pain—Lisinopril—dilated cardiomyopathy	0.00123	0.0033	CcSEcCtD
Dipyridamole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00123	0.0033	CcSEcCtD
Dipyridamole—Myalgia—Lisinopril—dilated cardiomyopathy	0.00123	0.0033	CcSEcCtD
Dipyridamole—Anxiety—Lisinopril—dilated cardiomyopathy	0.00123	0.00329	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00122	0.00327	CcSEcCtD
Dipyridamole—Discomfort—Lisinopril—dilated cardiomyopathy	0.00122	0.00326	CcSEcCtD
Dipyridamole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00121	0.00322	CcSEcCtD
Dipyridamole—Oedema—Lisinopril—dilated cardiomyopathy	0.00118	0.00316	CcSEcCtD
Dipyridamole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00118	0.00316	CcSEcCtD
Dipyridamole—Shock—Lisinopril—dilated cardiomyopathy	0.00116	0.00311	CcSEcCtD
Dipyridamole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00116	0.0031	CcSEcCtD
Dipyridamole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00116	0.00309	CcSEcCtD
Dipyridamole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00115	0.00308	CcSEcCtD
Dipyridamole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00115	0.00307	CcSEcCtD
Dipyridamole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00114	0.00305	CcSEcCtD
Dipyridamole—Asthenia—Furosemide—dilated cardiomyopathy	0.00113	0.00302	CcSEcCtD
Dipyridamole—Pruritus—Furosemide—dilated cardiomyopathy	0.00111	0.00298	CcSEcCtD
Dipyridamole—Hypotension—Lisinopril—dilated cardiomyopathy	0.0011	0.00295	CcSEcCtD
Dipyridamole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00108	0.00288	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00108	0.00288	CcSEcCtD
Dipyridamole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00106	0.00284	CcSEcCtD
Dipyridamole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00105	0.00282	CcSEcCtD
Dipyridamole—Somnolence—Lisinopril—dilated cardiomyopathy	0.00105	0.00281	CcSEcCtD
Dipyridamole—Dizziness—Furosemide—dilated cardiomyopathy	0.00104	0.00279	CcSEcCtD
Dipyridamole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00104	0.00278	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00273	CcSEcCtD
Dipyridamole—Fatigue—Lisinopril—dilated cardiomyopathy	0.00102	0.00272	CcSEcCtD
Dipyridamole—Pain—Lisinopril—dilated cardiomyopathy	0.00101	0.0027	CcSEcCtD
Dipyridamole—Vomiting—Furosemide—dilated cardiomyopathy	0.001	0.00268	CcSEcCtD
Dipyridamole—Rash—Furosemide—dilated cardiomyopathy	0.000994	0.00266	CcSEcCtD
Dipyridamole—Dermatitis—Furosemide—dilated cardiomyopathy	0.000993	0.00265	CcSEcCtD
Dipyridamole—Headache—Furosemide—dilated cardiomyopathy	0.000987	0.00264	CcSEcCtD
Dipyridamole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000974	0.0026	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000967	0.00258	CcSEcCtD
Dipyridamole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000939	0.00251	CcSEcCtD
Dipyridamole—Nausea—Furosemide—dilated cardiomyopathy	0.000936	0.0025	CcSEcCtD
Dipyridamole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000935	0.0025	CcSEcCtD
Dipyridamole—ABCB1—heart—dilated cardiomyopathy	0.000897	0.0028	CbGeAlD
Dipyridamole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000871	0.00233	CcSEcCtD
Dipyridamole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000848	0.00227	CcSEcCtD
Dipyridamole—Pruritus—Lisinopril—dilated cardiomyopathy	0.000837	0.00224	CcSEcCtD
Dipyridamole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000809	0.00216	CcSEcCtD
Dipyridamole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000782	0.00209	CcSEcCtD
Dipyridamole—Vomiting—Lisinopril—dilated cardiomyopathy	0.000752	0.00201	CcSEcCtD
Dipyridamole—Rash—Lisinopril—dilated cardiomyopathy	0.000746	0.00199	CcSEcCtD
Dipyridamole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000745	0.00199	CcSEcCtD
Dipyridamole—Headache—Lisinopril—dilated cardiomyopathy	0.000741	0.00198	CcSEcCtD
Dipyridamole—Nausea—Lisinopril—dilated cardiomyopathy	0.000702	0.00188	CcSEcCtD
Dipyridamole—PDE6G—Disease—RAC1—dilated cardiomyopathy	0.000171	0.000622	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00017	0.00062	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00017	0.000619	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000169	0.000618	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000168	0.000613	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000168	0.000613	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PSEN2—dilated cardiomyopathy	0.000168	0.000611	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CD36—dilated cardiomyopathy	0.000166	0.000606	CbGpPWpGaD
Dipyridamole—SLC29A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000165	0.000601	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000165	0.000601	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000164	0.000599	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000164	0.000599	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	0.000164	0.000598	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000164	0.000598	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000163	0.000595	CbGpPWpGaD
Dipyridamole—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000162	0.000592	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000162	0.000591	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000162	0.000591	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000159	0.000579	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000158	0.000576	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000158	0.000575	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000158	0.000575	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000158	0.000575	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000158	0.000575	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—RAC1—dilated cardiomyopathy	0.000157	0.000571	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000156	0.000569	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000156	0.000567	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000155	0.000565	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000154	0.000561	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000154	0.000561	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000154	0.00056	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000152	0.000555	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000151	0.000549	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000151	0.000549	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00015	0.000547	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00015	0.000546	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00015	0.000546	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000149	0.000545	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000148	0.000541	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000148	0.00054	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000148	0.00054	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—RAF1—dilated cardiomyopathy	0.000147	0.000537	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000147	0.000535	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000147	0.000535	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000147	0.000535	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—EGFR—dilated cardiomyopathy	0.000146	0.000533	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000145	0.000527	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000145	0.000527	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000142	0.000517	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000141	0.000513	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00014	0.000512	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00014	0.000512	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00014	0.000511	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	0.00014	0.00051	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000138	0.000502	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000137	0.000498	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000136	0.000498	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000136	0.000496	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000136	0.000494	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000134	0.000489	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—RAF1—dilated cardiomyopathy	0.000134	0.000489	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000134	0.000489	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000134	0.000489	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000485	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000485	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000132	0.000482	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	0.000132	0.000481	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000131	0.000479	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000131	0.000476	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000131	0.000476	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000131	0.000476	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000129	0.00047	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000129	0.000469	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000128	0.000468	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000128	0.000466	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000128	0.000465	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—RAF1—dilated cardiomyopathy	0.000126	0.00046	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000126	0.000458	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000125	0.000455	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000125	0.000455	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000125	0.000455	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000125	0.000454	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000125	0.000454	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—RAF1—dilated cardiomyopathy	0.000124	0.000453	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ITGB1—dilated cardiomyopathy	0.000124	0.000453	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000124	0.000451	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000123	0.000448	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000123	0.000448	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000122	0.000446	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000122	0.000444	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000121	0.000442	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000121	0.000442	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000121	0.000442	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000121	0.000442	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000121	0.000442	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000121	0.00044	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—EGFR—dilated cardiomyopathy	0.00012	0.000439	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—EGFR—dilated cardiomyopathy	0.00012	0.000439	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00012	0.000438	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00012	0.000437	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000119	0.000436	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000119	0.000435	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000118	0.000431	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000117	0.000428	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000116	0.000424	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000116	0.000424	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000116	0.000423	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000116	0.000422	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000116	0.000422	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—GPX1—dilated cardiomyopathy	0.000116	0.000422	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—RAF1—dilated cardiomyopathy	0.000115	0.000421	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000115	0.000419	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—RAF1—dilated cardiomyopathy	0.000115	0.000418	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AGT—dilated cardiomyopathy	0.000114	0.000416	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000114	0.000416	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000114	0.000416	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000114	0.000415	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000114	0.000415	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—RAF1—dilated cardiomyopathy	0.000114	0.000414	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ITGB1—dilated cardiomyopathy	0.000114	0.000414	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—RAF1—dilated cardiomyopathy	0.000113	0.000412	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—CD36—dilated cardiomyopathy	0.000113	0.000411	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000113	0.000411	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000112	0.000409	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000111	0.000406	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000111	0.000405	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00011	0.000401	CbGpPWpGaD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000109	0.000398	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000109	0.000398	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000109	0.000398	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000108	0.000394	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000106	0.000386	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD36—dilated cardiomyopathy	0.000106	0.000386	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000105	0.000383	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000105	0.000381	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000105	0.000381	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000104	0.00038	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000104	0.00038	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000104	0.00038	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—RAF1—dilated cardiomyopathy	0.000104	0.000379	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000103	0.000374	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000373	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000102	0.000371	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AGT—dilated cardiomyopathy	0.000101	0.00037	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000101	0.000367	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000101	0.000367	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.0001	0.000365	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0001	0.000365	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.99e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—RAC1—dilated cardiomyopathy	9.98e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.7e-05	0.000354	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.69e-05	0.000353	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD36—dilated cardiomyopathy	9.68e-05	0.000353	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.58e-05	0.000349	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AGT—dilated cardiomyopathy	9.54e-05	0.000348	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	9.4e-05	0.000343	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.38e-05	0.000342	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.32e-05	0.00034	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.32e-05	0.00034	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.32e-05	0.00034	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—RAC1—dilated cardiomyopathy	9.21e-05	0.000336	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—RAC1—dilated cardiomyopathy	9.21e-05	0.000336	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—RAC1—dilated cardiomyopathy	9.13e-05	0.000333	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.09e-05	0.000331	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.96e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.84e-05	0.000322	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.76e-05	0.000319	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	8.75e-05	0.000319	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.66e-05	0.000316	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.66e-05	0.000316	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—dilated cardiomyopathy	8.52e-05	0.000311	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	8.5e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.46e-05	0.000308	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—dilated cardiomyopathy	8.43e-05	0.000307	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—dilated cardiomyopathy	8.43e-05	0.000307	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—RAC1—dilated cardiomyopathy	8.43e-05	0.000307	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	8.41e-05	0.000307	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.34e-05	0.000304	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.31e-05	0.000303	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CD36—dilated cardiomyopathy	8.19e-05	0.000299	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—RAF1—dilated cardiomyopathy	8.03e-05	0.000293	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.01e-05	0.000292	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—RAF1—dilated cardiomyopathy	7.92e-05	0.000289	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.92e-05	0.000289	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—dilated cardiomyopathy	7.86e-05	0.000287	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.81e-05	0.000285	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—dilated cardiomyopathy	7.79e-05	0.000284	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—dilated cardiomyopathy	7.76e-05	0.000283	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.72e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.7e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.6e-05	0.000277	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.59e-05	0.000277	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.57e-05	0.000276	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.56e-05	0.000276	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.53e-05	0.000275	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AGT—dilated cardiomyopathy	7.37e-05	0.000269	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.24e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AGT—dilated cardiomyopathy	7.2e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.17e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.17e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.14e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—dilated cardiomyopathy	7.12e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.05e-05	0.000257	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.99e-05	0.000255	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.86e-05	0.00025	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AGT—dilated cardiomyopathy	6.74e-05	0.000246	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.62e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—RAF1—dilated cardiomyopathy	6.62e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AGT—dilated cardiomyopathy	6.56e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.53e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.45e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.39e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AGT—dilated cardiomyopathy	6.16e-05	0.000225	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—RAF1—dilated cardiomyopathy	6.11e-05	0.000223	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—RAF1—dilated cardiomyopathy	6.11e-05	0.000223	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—RAF1—dilated cardiomyopathy	6.05e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.94e-05	0.000217	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.94e-05	0.000217	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.9e-05	0.000215	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.8e-05	0.000211	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGT—dilated cardiomyopathy	5.64e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—RAF1—dilated cardiomyopathy	5.59e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.51e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—dilated cardiomyopathy	5.43e-05	0.000198	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.43e-05	0.000198	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.29e-05	0.000193	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.28e-05	0.000193	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.18e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RAF1—dilated cardiomyopathy	5e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.97e-05	0.000181	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.94e-05	0.00018	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.68e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.55e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.54e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—dilated cardiomyopathy	4.54e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.28e-05	0.000156	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—dilated cardiomyopathy	4.19e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—dilated cardiomyopathy	4.19e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—dilated cardiomyopathy	4.15e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.91e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—dilated cardiomyopathy	3.83e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.43e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.21e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.12e-05	0.000114	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.93e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.68e-05	9.78e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.31e-05	8.42e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.25e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.03e-05	7.39e-05	CbGpPWpGaD
